Giving immunotherapy before surgery for cancer treatment may establish a new standard of care, Elizabeth Tracey reports
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
An immunotherapy agent called nivolumab given before surgery in people with lung cancer dramatically lengthened the interval before cancer returned, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, is thrilled. Nelson: Will we …